Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer: study protocol for a double-blind, randomized, placebo-controlled, clinical multicenter trial

Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer: study protocol for a double-blind, randomized, placebo-controlled, clinical multicenter trial

Abstract Background Despite the high prevalence of insomnia in patients with advanced cancer, there are no randomized controlled trials on pharmacological interventions for insomnia in this group of patients. A variety of pharmacological agents is recommended to manage sleep disturbance for insomnia...

Full description

Bibliographic Details
Main Authors: Gunnhild Jakobsen, Morten Engstrøm, Ørnulf Paulsen, Karin Sjue, Sunil X. Raj, Morten Thronæs, Marianne Jensen Hjermstad, Stein Kaasa, Peter Fayers, Pål Klepstad
Format: Article
Language:English
Published: BMC 2018-12-01
Series:Trials
Subjects:
Advanced cancer
Insomnia
Pharmacological treatment
Randomized controlled trial
Online Access:http://link.springer.com/article/10.1186/s13063-018-3088-3

Internet

http://link.springer.com/article/10.1186/s13063-018-3088-3

Similar Items